Big Tobacco firms like Philip Morris International, Altria, and British American Tobacco already dominate the surging nicotine pouch category through prior deals for Zyn, On!, and Velo, using these smoke-free assets to offset declining cigarette volumes amid rapid U.S. sales growth exceeding 1,300% since 2019. Trader sentiment centers on whether remaining independent or smaller players will face similar buyouts, driven by the category's projected expansion to tens of billions globally, ongoing FDA marketing authorizations that favor established portfolios, and competitive pressures including Zyn's recent share erosion. Key near-term catalysts include further regulatory clearances for new variants, factory investments, and any announced M&A activity targeting brands with strong retail traction or adult consumer appeal.